AI startup roundup: Anthropic raises $580M, harnessing influencers

Also, startup founded by Apple, Google and Uber AI engineers create ML tool for unstructured data.

Ben Wodecki, Jr. Editor

May 9, 2022

4 Min Read

Also, startup founded by Apple, Google and Uber AI engineers create ML tool for unstructured data.

Every week, AI Business brings you the latest startup news.

From funding rounds to acquisitions, and product launches to partnerships, AI Business covers all things artificial intelligence.

Be sure to check out the deals and products roundup and subscribe to the AI Business newsletter to get content straight to your inbox.

Funding blitz

Startup: Anthropic is a San Francisco-based company that is attempting to build better explainable AI. Founded by Dario Amodei, formerly OpenAI’s VP of research.

Latest funding: $580 million, series B

Lead investor: Sam Bankman-Fried, the founder and CEO of FTX

Other investors: The Center for Emerging Risk Research, former Skype engineer Jaan Tallinn, Nishad Singh, director of engineering at FTX, Caroline Ellison, co-CEO at Alameda Research, and Infotech Consulting CEO and founder Jim McClave

Funding plans: The startup will use the funds to continue its research, including exploring predictable scaling properties of machine learning systems.


Startup: Accern provides AI-powered apps and NLP models so companies can analyze online conversations related to their brand

Latest funding: $20 million, series B

Lead investors: Mighty Capital, Fusion Fund

Other investors: Tribe Capital, Shasta Ventures, Gaingels

Funding plans: others. The newly secured capital will go towards expanding into new markets and R&D on Accern’s AI technologies.


Startup: Synthesis AI is a San Francisco-based company develops synthetic data tools designed to build computer vision AI models.

Latest funding: $17 million, series A

Lead investor: 468 Capital

Other investors: Sorenson Ventures, Strawberry Creek Ventures, Bee Partners, PJC, iRobot Boom Capital, Kubera Venture Capital

Funding plans: Synthesis will use the funds to hire new staff, expand its research and introduce new products designed to build more advanced computer vision models − faster.


Startup: Mavrck is a software company that has built an Influencer Marketing Platform designed to automate influencer and marketing functions.

Latest funding: $135 million, private equity round

Investor: Summit Partners

Funding plans: The startup is using part of its funds to acquire Later, which makes scheduling tools for social media sites.


Startup: Movable Ink is a New York-based startup that developed an intelligent content platform that automatically personalizes content for the user, based on data.

Latest funding: $55 million, series D

Lead investor: Silver Lake Waterman

Other investors: Contour Venture Partners, Intel Capital

Funding plans: Movable Ink now plans to expand its team from 550 employees to more than 700 by 2023.


Startup: Traceable AI is developing an end-to-end cloud app security solution.

Latest funding: $60 million, series B

Lead investor: IVP

Other investors: BIG Labs, Unusual Ventures, Tiger Global Management

Funding plans: Traceable will use the cash to scale product development and recruitment.


Figure 1: 6630.jpg

Startup: Galileo, founded by engineers from Apple, Google and Uber AI, develops ML data intelligence platforms for unstructured data.

Latest funding: $5.1 million, seed funding

Lead investors: The Factory

Other investor: Anthony Goldbloom, co-founder and CEO at Kaggle

Funding plans: The company plans to use the funding to hire across all departments and accelerate research and development.


Startup: Finbots.AI uses its AI-powered credit scorecard system to allow financial institutions to process applications in real time.

Latest funding: $3 million, series A

Lead investor: Accel

Funding plans: The funds will be used towards accelerating product enhancement and recruiting senior talent.


Startup: Imagene AI is a Tel Aviv-based precision oncology diagnosis company that is developing precision medicine for cancer.

Latest funding: $21.5 million ($3 million in seed funding, $18.5 million in series A)

Lead investors: Seed funding - Blumberg Capital, series A - former Oracle CEO Larry Ellison, Dr. David Agus, Eyal Gura

Funding plans: Cash to go towards funding clinical trials.


To keep up with news coverage, subscribe to the AI Business newsletter.

About the Author(s)

Ben Wodecki

Jr. Editor

Ben Wodecki is the Jr. Editor of AI Business, covering a wide range of AI content. Ben joined the team in March 2021 as assistant editor and was promoted to Jr. Editor. He has written for The New Statesman, Intellectual Property Magazine, and The Telegraph India, among others. He holds an MSc in Digital Journalism from Middlesex University.

Keep up with the ever-evolving AI landscape
Unlock exclusive AI content by subscribing to our newsletter!!

You May Also Like